Silveira et al. demonstrated that the distribution of AML patients in accordance with the created novel scoring system integrating both cytogenetic/molecular information and clinical prognostic features such as age (>45 years), white blood cell count (<1.5 or >30.0 × 103/μL), and low albumin levels (<3.8 g/dL) were associated with worse overall survival in test cohorts [45]. Here, ALB is linked to acute myeloid leukemia.